首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >A PRELIMINARY IN-SILICO ANALYSIS OF OCIMUM SANCTUM FLAVONOIDS, ORIENTIN AND VICENIN-1, AS POTENTIAL DRUGS AGAINST SARS-COV-2 INFECTION
【24h】

A PRELIMINARY IN-SILICO ANALYSIS OF OCIMUM SANCTUM FLAVONOIDS, ORIENTIN AND VICENIN-1, AS POTENTIAL DRUGS AGAINST SARS-COV-2 INFECTION

机译:ISARS-COV-2感染的潜在药物,SARS-COV-2感染的潜在药物的初步硅藻分析

获取原文
           

摘要

The SARS-CoV-2 virus is the causative agent of the Covid-19 pandemic. The major proteins of this virus, like covid main protease RNA dependent RNA polymerase, are being extensively studied with the hopes of finding an effective molecule that would bind to these proteins and lead to their inhibition. The inhibition of these critical viral proteins would hamper SARS-CoV-2 infection. With most of the currently available drugs falling short of providing an absolute cure and the reported side-effects of the current medications, a lot of phytochemicals are being investigated for their efficacy against the viral proteins. In our preliminary in-silico analysis, we found that the Ocimum Sanctum (Holy Basil/Tulsi) flavonoids, orientin, and vicenin-1, showed energetically favoured docking with the functionally critical amino acid residues of covid main protease, RNA dependent RNA polymerase, Spike protein, nucleocapsid, and 3a proteins of SARS-CoV-2 virus. These results hold promise for orientin and vicenin-1 to be further investigated as potential therapeutic drugs against SARS-CoV-2 infections.
机译:SARS-COV-2病毒是Covid-19流行病的致病剂。这种病毒的主要蛋白质,如Covid主蛋白酶RNA依赖性RNA聚合酶,并希望找到将与这些蛋白质结合并导致其抑制的有效分子并导致它们的抑制作用。抑制这些关键病毒蛋白质会阻碍SARS-COV-2感染。随着目前目前可用的大部分药物缺乏提供绝对治愈和目前药物的副作用,正在研究许多植物化学物质以抵御病毒蛋白的疗效。在我们初步的硅藻分析中,我们发现,OCimum Sanctum(神圣罗勒/塔尔西)类黄酮类化合物,Orientin和Vicenin-1在Covid主蛋白酶,RNA依赖性RNA聚合酶的功能临界氨基酸残基, SARS-COV-2病毒的穗蛋白,核衣壳和3A蛋白。这些结果持有东方和vicenin-1的承诺进一步调查作为针对SARS-COV-2感染的潜在治疗药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号